Revona Bio

Serna Bio

This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.

Novarna

This company develops an artificial intelligence platform to design and validate RNA therapeutics for biopharmaceutical partners.

Ribometrix

The company develops small molecule therapeutics targeting RNA structures to treat human diseases for pharmaceutical partners and patients with cancer or neurodegenerative conditions.

Ribonaut Therapeutics

Ribonaut Therapeutics develops small molecule drugs that target and degrade disease-causing RNA to treat neurological conditions and movement disorders for human patients.

Revanta

Revanta develops an artificial intelligence platform for drug design to support biotechnology companies.

Redona Therapeutics

This biotechnology company develops small molecule therapies targeting nucleic acid regulators to treat cancer and autoimmune diseases for healthcare providers and pharmaceutical partners.

Veritas In Silico

The company develops an AI-driven drug discovery platform for identifying mRNA-targeted medicines for pharmaceutical industry partners.

Romix Bio

This company develops a molecular scan platform using cell-free RNA liquid biopsy and artificial intelligence for disease profiling and drug development for biotechnology customers.